Join our journey
A Norwegian life-science company solving one of the largest medical challenges we are facing.
20 minutes delay

Lifecare as an investment

Lifecare’s purpose is to develop and license technology for medical use, including facilitating the production and sale of medical devices. Today people with diabetes are dependent on a painful and more than 40-year-old technology. Lifecare’s solutions have the potential to revolutionise the field of continuous glucose measurement for more the more than 530 million people living with diabetes.

 

Top 10 shareholders

Updated February 28, 2024
Name
Holdings
Share
Citizen
Teigland Eiendom AS
24 691 829
18.31 %
NOR
Lacal AS
21 387 712
15.86 %
NOR
VPF Nordea Avkastning
8 755 413
6.49 %
NOR
Tjelta AS
8 000 000
5.93 %
NOR
Spit Air AS
3 087 735
2.29 %
NOR
Patricia Rodrigues Da Costa Sandquist
2 752 000
2.04 %
NOR
Nordnet Livsforsikring AS
2 718 261
2.02 %
NOR
Lt Finans As
2 434 000
1.80 %
NOR
Even Harald Einarsen
2 424 000
1.80 %
NOR
BNP Paribas
1 812 600
1.34 %
CHE
Swipe for more data

Contact

Investor relations